Search

A new article in STAT News by Eric Boodman (one of our favourite phage journalists!) talks about how a phage has been found that kills Mallory Smith's infective Burkholderia cepacia isolate. In Mallory's honour, the phage has been named BCM

BCM Tailor Labs is a new initiative out of Baylor College of Medicine focused on phage therapy.

Professor Craig Winstanley, Dr. Jo Fothergill and Dr. Rachel Floyd at the University of Liverpool are seeking an enthusiastic and motivated postdoctoral microbiologist to join a project entitled "Phage therapy to treat bacterial urinary tra

Dr. Matt Daugherty at UCSD is hiring a lab manager. From Twitter: "If you'd like to work for a few years (e.g. before grad school or med school) in beautiful San Diego, and interested in host-pathogen evolution, virology or biochemical mech

We know a lot about how phages expand their host ranges, but not so much about how they shrink them. A new Scientific Reports paper by Tzvi Holtzman (Israel Institute for Biological Research) and colleagues shows how T7 phage limits futile

A new crAssphage paper by Tanvi Honap (University of Oklahoma) and colleagues shows that crAssphage prevalence correlates with more industrialized lifestyles. Paper | News Article

Dr. Matt Daugherty at UCSD is hiring a lab manager. From Twitter: "If you'd like to work for a few years (e.g. before grad school or med school) in beautiful San Diego, and interested in host-pathogen evolution, virology or biochemical mech

Could destroying phages after they've found their target help make phages work more like drugs? In a new PNAS paper, Huan Peng (UC Santa Barbara) and colleagues describe how they've conjugated phages to gold nanorods, which can "cook" nearb

We know a lot about how phages expand their host ranges, but not so much about how they shrink them. A new Scientific Reports paper by Tzvi Holtzman (Israel Institute for Biological Research) and colleagues shows how T7 phage limits futile

Professor Craig Winstanley, Dr. Jo Fothergill and Dr. Rachel Floyd at the University of Liverpool are seeking an enthusiastic and motivated postdoctoral microbiologist to join a project entitled "Phage therapy to treat bacterial urinary tra

This week, we bring you an interview with Michele Wales, founder of the legal firm InHouse Patent Counsel. She tells us about the unique challenges phage companies face in protecting their IP, and why she's optimistic about what's to come.

PhagoMed attended the Biotech Showcase 2020 this week in San Francisco, and announced it is looking to raise $16 million from US and European investors to bring its phage products to the clinic (watch this interview with CEO Alexander Belcr

Adaptive Phage Therapeutics was named one of five biotech companies to watch in 2020 by BioBuzz.

Hannah Hampton (University of Otago) and colleagues published a review in Nature on the arms race between bacteria and phages.

Johanna Sweere (Stanford University) and colleagues developed a mouse model of chronic Pseudomonas wound infection that does not rely on impaired immunity and lasts 10 days without causing sepsis/excessive morbidity. Advances in Wound Care

A nice Inside Science article on the underestimated roles of viruses in chemical cycles and climate, and the research that's amassing on the subject. Phage researchers Lindsey Solden, Gary Trubl, Jennifer Brum, Martha Clokie and more are in

The 4th Phages for Global Health workshop started this week in Tanzania! The 25 participants come from Kenya, Rwanda, Tanzania and Uganda.

Save the date for Viruses of Microbes 2020, which will be hosted in Guimarães, Portugal July 13-17, 2020. Also, students and postdocs, stay tuned: Phage Directory will be giving out travel awards!

Australia is becoming a hotspot for phage therapy research and innovation. In this in-depth Sydney Morning Herald feature, Jeremy Barr describes his role in Tom Patterson's phage therapy case (Jeremy now runs his own phage research lab at M

Johanna Sweere (Stanford University) and colleagues developed a mouse model of chronic Pseudomonas wound infection that does not rely on impaired immunity and lasts 10 days without causing sepsis/excessive morbidity. Advances in Wound Care